ONC201 and imipridones: Anti-cancer compounds with clinical efficacy-Reference-Cited by-同舟云学术

ONC201 and imipridones: Anti-cancer compounds with clinical efficacy

Published:2020-12 Issue:12 Volume:22 Page:725-744
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Prabhu Varun Vijay,Morrow Sara,Rahman Kawakibi Abed,Zhou Lanlan,Ralff Marie,Ray Jocelyn,Jhaveri Aakash,Ferrarini Isacco,Lee Young,Parker Cassandra,Zhang Yiqun,Borsuk Robyn,Chang Wen-I,Honeyman Joshua N.,Tavora Fabio,Carneiro Benedito,Raufi Alexander,Huntington Kelsey,Carlsen Lindsey,Louie Anna,Safran Howard,Seyhan Attila A.,Tarapore Rohinton S.,Schalop Lee,Stogniew Martin,Allen Joshua E.,Oster Wolfgang,El-Deiry Wafik S.

Funder

National Cancer Institute

American Cancer Society

Publisher

Elsevier BV

Subject

Cancer Research

Reference134 articles.

1. G-protein-coupled receptors and cancer;Dorsam;Nat Rev Cancer,2007

2. Targeting G protein coupled receptor-related pathways as emerging molecular therapies;Ghanemi;Saudi Pharm J,2015

3. G protein-coupled receptors: novel targets for drug discovery in cancer;Lappano;Nat Rev Drug Discov,2011

4. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer;O'Hayre;Nat Rev Cancer,2013

5. G protein-coupled receptor signaling in stem cells and cancer;Lynch;Int J Mol Sci,2016

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of novel imipridone derivatives with potent anti-cancer activities as human caseinolytic peptidase P (hClpP) activators;Bioorganic Chemistry;2024-12

2. ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells;Neoplasia;2024-09

3. Overview of BH3 mimetics in ovarian cancer;Cancer Treatment Reviews;2024-09

4. Neuroendocrine Prostate Cancer Drivers SOX2 and BRN2 Confer Differential Responses to Imipridones ONC201, ONC206, and ONC212 in Prostate Cancer Cell Lines;2024-08-30

5. Neuroendocrine differentiation (ND) in sensitivity of neuroendocrine tumor (NET) cells to ONC201/TIC10 cancer therapeutic;2024-08-30